Sawai Pharmaceutical Co Has Reached Settlement With Asahi Kasei Pharma Regarding Patent Infringement Lawsuit Concerning Teriparatide For Subcutaneous Injection 56.5μg

SAWAI group

21/10/2025 24:33

Oct 21 (Reuters) - Asahi Kasei Corp 3407.T:

SAWAI GROUP HOLDINGS CO - SAWAI PHARMACEUTICAL CO HAS REACHED SETTLEMENT WITH ASAHI KASEI PHARMA REGARDING PATENT INFRINGEMENT LAWSUIT CONCERNING TERIPARATIDE FOR SUBCUTANEOUS INJECTION 56.5ΜG

SAWAI GROUP HOLDINGS CO - SAWAI PHARMACEUTICAL PAID ASAHI KASEI PHARMA 4 BILLION YEN AS A SETTLEMENT, AND ASAHI KASEI PHARMA WAIVED ANY OTHER CLAIMS AGAINST SAWAI PHARMACEUTICAL

Source text: ID:nTSvt8c9e2

Further company coverage: 3407.T